Hale G - Search Results

1

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.

Hale G, Zhang MJ, Bunjes D, Prentice HG, Spence D, Horowitz MM, Barrett AJ, Waldmann H. Hale G, et al. Blood. 1998 Dec 15;92(12):4581-90. Blood. 1998. PMID: 9845524 Free article. Clinical Trial.

2

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, Horowitz MM. Lee SJ, et al. Among authors: hale ga. Blood. 2002 Jul 15;100(2):406-14. doi: 10.1182/blood.v100.2.406. Blood. 2002. PMID: 12091329 Free article.

3

Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

Oh H, Loberiza FR Jr, Zhang MJ, Ringdén O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin JH, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, Giller RH, Goldman JM, Hale GA, Harris RE, Henslee-Downey J, Kolb HJ, Litzow MR, McCarthy PL, Neudorf SM, Serna DS, Socié G, Tiberghien P, Barrett AJ. Oh H, et al. Among authors: hale ga. Blood. 2005 Feb 15;105(4):1408-16. doi: 10.1182/blood-2004-06-2385. Epub 2004 Oct 14. Blood. 2005. PMID: 15486071 Free article.

4

What can be done to prevent graft versus host disease?

Waldmann H, Cobbold S, Hale G. Waldmann H, et al. Among authors: hale g. Curr Opin Immunol. 1994 Oct;6(5):777-83. doi: 10.1016/0952-7915(94)90084-1. Curr Opin Immunol. 1994. PMID: 7826534 Review.

5

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.

Hale G, Waldmann H. Hale G, et al. J Hematother. 1994 Spring;3(1):15-31. doi: 10.1089/scd.1.1994.3.15. J Hematother. 1994. PMID: 7922004 Clinical Trial.

6

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.

Hale G, Waldmann H. Hale G, et al. Bone Marrow Transplant. 1994 May;13(5):597-611. Bone Marrow Transplant. 1994. PMID: 8054913

7

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.

Hale G, Waldmann H. Hale G, et al. Bone Marrow Transplant. 1996 Mar;17(3):305-8. Bone Marrow Transplant. 1996. PMID: 8704678

8

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.

Hale G, Waldmann H. Hale G, et al. Blood. 1998 Apr 15;91(8):3079-83. Blood. 1998. PMID: 9531622 Free article.

9

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.

Hale G, Jacobs P, Wood L, Fibbe WE, Barge R, Novitzky N, Toit C, Abrahams L, Thomas V, Bunjes D, Duncker C, Wiesneth M, Selleslag D, Hidajat M, Starobinski M, Bird P, Waldmann H. Hale G, et al. Bone Marrow Transplant. 2000 Jul;26(1):69-76. doi: 10.1038/sj.bmt.1702477. Bone Marrow Transplant. 2000. PMID: 10918407

10

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.

Waldmann H, Hale G, Cobbold S. Waldmann H, et al. Among authors: hale g. Philos Trans R Soc Lond B Biol Sci. 2001 May 29;356(1409):659-63. doi: 10.1098/rstb.2001.0841. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11375069 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

750 results

Search Page